These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 14962789)

  • 21. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
    Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
    Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value.
    Martín-Dávila P; Fortún J; Gutiérrez C; Martí-Belda P; Candelas A; Honrubia A; Barcena R; Martínez A; Puente A; de Vicente E; Moreno S
    J Clin Virol; 2005 Jun; 33(2):138-44. PubMed ID: 15911429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and application of a novel multiplex polymerase chain reaction for semi-quantitation of human Cytomegalovirus in clinical specimens.
    Madhavan HN; Sowmya P; Therese KL; Malathi J
    J Virol Methods; 2007 May; 141(2):166-72. PubMed ID: 17222918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and monitoring of cytomegalovirus infection in renal transplant patients by quantitative real-time PCR.
    Madi N; Al-Nakib W; Mustafa AS; Saeed T; Pacsa A; Nampoory MR
    Med Princ Pract; 2007; 16(4):268-73. PubMed ID: 17541291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of quantitative PCR and antigenemia in cytomegalovirus infection in renal transplant recipients.
    Bordils A; Plumed JS; Ramos D; Beneyto I; Mascarós V; Molina JM; Cordoba J; García J; Crúz JM
    Transplant Proc; 2005 Nov; 37(9):3756-9. PubMed ID: 16386529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
    Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
    Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplex polymerase chain reaction for the evaluation of cytomegalovirus DNA load in organ transplant recipients.
    Nazzari C; Gaeta A; Lazzarini M; Castelli TD; Mancini C
    J Med Virol; 2000 Jun; 61(2):251-8. PubMed ID: 10797382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions.
    Kubar A; Saygun I; Ozdemir A; Yapar M; Slots J
    J Periodontal Res; 2005 Apr; 40(2):97-104. PubMed ID: 15733143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients.
    Gerna G; Percivalle E; Baldanti F; Sarasini A; Zavattoni M; Furione M; Torsellini M; Revello MG
    New Microbiol; 1998 Jul; 21(3):293-308. PubMed ID: 9699213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of pp65 antigenemia, quantitative PCR and DNA hybrid capture for detection of cytomegalovirus in transplant recipients and AIDS patients.
    Mhiri L; Kaabi B; Houimel M; Arrouji Z; Slim A
    J Virol Methods; 2007 Jul; 143(1):23-8. PubMed ID: 17336402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
    Zhang C; Shen K; Jiang Z; He X
    Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of human cytomegalovirus glycoprotein B genotypes using real-time quantitative PCR in immunocompromised Chinese patients.
    Fan J; Zhang X; Chen XM; Gao HN; Yang MF; Zhao H; Hu JH; Ma WH
    J Virol Methods; 2009 Sep; 160(1-2):74-7. PubMed ID: 19406161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of cytomegalovirus DNA by a fully automated real-time PCR for early diagnosis and monitoring of active viral infection in solid organ transplant recipients.
    Boaretti M; Sorrentino A; Zantedeschi C; Forni A; Boschiero L; Fontana R
    J Clin Virol; 2013 Feb; 56(2):124-8. PubMed ID: 23182772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test.
    Abbate I; Finnstrom N; Zaniratti S; Solmone MC; Selvaggini S; Bennici E; Neri S; Brega C; Paterno M; Capobianchi MR
    J Virol Methods; 2008 Jul; 151(1):61-5. PubMed ID: 18462815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between pp65 antigenemia assay and quantitative real-time polymerase chain reaction for detection of active cytomegalovirus infection in routine diagnostics.
    Lugert R; Reichard U; Hufert FT; Gross U
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):192-5. PubMed ID: 19748432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.